Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Funda Meric-BernstamMichael RothePam K MangatElizabeth Garrett-MayerRodolfo GutierrezEugene R AhnTimothy L CannonSteven Francis PowellJohn C KraussChristopher M ReynoldsMargaret von MehrenDeepti BehlCarmen J CalfaHerbert L DuvivierHenry G KaplanMichael B LivingstonManish R SharmaWalter J UrbaGina N GranthamDominique C HinshawAbigail GregorySusan HalabiRichard L SchilskyPublished in: JCO precision oncology (2023)
mutations.